Immunocore Holdings plc

IMCR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$177-$10,300$5,023-$23,551
Dep. & Amort.$798$780$854$1,166
Deferred Tax$0$0$0$0
Stock-Based Comp.$9,837$10,033$9,489$8,667
Change in WC-$1,324$26,736-$7,610-$8,248
Other Non-Cash-$13,590-$1,285-$7,321$8,015
Operating Cash Flow-$4,456$25,964$435-$13,951
Investing Activities
PP&E Inv.-$748-$414-$298-$3,584
Net Acquisitions$0$0$0$44
Inv. Purchases$0-$30,000$0$0
Inv. Sales/Matur.$6,000$0$10,000$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$5,252-$30,414$9,702-$3,540
Financing Activities
Debt Repay.$0$0$0-$402,500
Stock Issued$0$3,714$2,561$525
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,866-$44-$10$350,464
Financing Cash Flow$1,866$3,670$2,551-$51,511
Forex Effect$7,818$11,868$8,426-$13,034
Net Chg. in Cash$10,480$11,088$21,114-$82,036
Supplemental Information
Beg. Cash$487,933$476,845$455,731$537,767
End Cash$498,413$487,933$476,845$455,731
Free Cash Flow-$5,204$25,550$137-$17,535